A Double-Blind, Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Food allergy immunotherapy (Primary)
- Indications Milk hypersensitivity
- Focus Therapeutic Use
- Acronyms MILES
- Sponsors DBV Technologies
- 26 Feb 2018 Preliminary results published in a DBV Technologies Media Release.
- 16 Dec 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2018.
- 16 Dec 2016 Status changed from recruiting to active, no longer recruiting.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History